Track: Pediatric Pharmacology

Pediatric Pharmacology

Pediatric pharmacology addresses the unique ways in which children absorb, metabolize, and respond to medications. This session will explore current practices, research breakthroughs, and regulatory considerations in pediatric drug development and prescribing. Discussions will highlight age-specific dosing, safety, adverse effects, and innovations in pharmacotherapy across pediatric age groups—from neonates to adolescents. 

Age-Specific Drug Metabolism and Pharmacokinetics:
Examines how developmental changes in organ systems affect drug absorption, distribution, metabolism, and excretion in neonates, infants, and children.

Pediatric Drug Dosing and Safety:
Focuses on individualized dosing strategies, therapeutic drug monitoring, and minimizing medication errors in pediatric practice.

Adverse Drug Reactions and Drug Interactions:
Highlights common and rare adverse effects in children, methods for detection, and strategies to manage and prevent harmful drug interactions.

Neonatal Pharmacology:
Covers pharmacologic challenges and treatment protocols in the neonatal intensive care unit (NICU), including antibiotics, sedatives, and nutrition-related drugs.

Pediatric Clinical Trials and Drug Development:
Discusses ethical considerations, regulatory frameworks, and methodologies for conducting clinical trials and approving new drugs for pediatric populations.

Pharmacogenomics in Children:
Explores how genetic differences affect drug responses in pediatric patients and how personalized medicine is being applied in pediatrics.

Antibiotic Stewardship in Pediatric Care:
Addresses appropriate antibiotic prescribing, resistance concerns, and implementation of stewardship programs in hospitals and primary care settings.

Medication Compliance and Formulation Innovations:
Looks at child-friendly drug formulations (e.g., chewables, liquids, dissolvables), strategies to improve adherence, and caregiver education.